Horner’s Syndrome and Thyroid NeoplasmsLeuchter I.a · Becker M.b · Mickel R.c · Dulguerov P.a
aDepartment of Otolaryngology, Head and Neck Surgery and bDivision of Diagnostic Radiology, Geneva University Hospital, Geneva, Switzerland; cDivision of Head and Neck Surgery, University of California at Los Angeles and the West Los Angeles VA Medical Center, LosAngeles, Calif., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Although thyroid goiter is a common condition, it rarely results in Horner’s syndrome. We report a case of a patient with an intrathoracic multinodular goiter complicated by Horner’s syndrome. Benign thyroid disease was confirmed pathologically, and the patient’s symptoms improved after surgery. In the literature, the major cause of Horner’s syndrome is neoplasia, with malignant lesions being twice as frequent as benign tumors. An extensive review of the literature demonstrates a different repartition for thyroid neoplasia: including our case, 38 cases of Horner’s syndrome secondary to a benign thyroid tumor are described, against only 8 cases caused by a thyroid carcinoma. We conclude that contrary to the commonly held opinion, Horner’s syndrome is more often due to benign thyroid diseases than to thyroid malignancies.
© 2002 S. Karger AG, Basel
Horner F: Über eine Form von Ptosis. Klin Monatsbl Augenheilkd 1869;7:193–198.
Giles CL, Henderson JW: Horner’s syndrome: An analysis of 216 cases. Am J Ophthalmol 1958;46:289–296.
- Maloney WF, Younge BR, Moyer NJ: Evaluation of the causes and accuracy of pharmacologic localization in Horner’s syndrome. Am J Ophthalmol 1980;90:394–402.
- Wilhelm H, Ochsner H, Kopycziok E, Trauzettel-Klosinski S, Schiefer U, Zrenner E: Horner’s syndrome: A retrospective analysis of 90 cases and recommendations for clinical handling. Ger J Ophthalmol 1992;1:96–102.
- Keane JR: Oculosympathetic paresis: Analysis of 100 hospitalized patients. Arch Neurol 1979;36:13–15.
Grimson BS, Thompson HS: Horner’s syndrome: Overall view of 120 cases; in Thompson HS, Doroff R (eds): Topics in Neuro-Ophthalmology. Baltimore, Williams & Wilkins, 1979.
- Smith PG, Dyches TJ, Burde RM: Topographic analysis of Horner’s syndrome. Otolaryngol Head Neck Surg 1986;94:451–457.
Herbut PA, Watson JS: Tumor of the thoracic inlet producing the Pancoast syndrome. Arch Pathol 1946;42:88–103.
Jaffe NS: Localization of lesions causing Horner’s syndrome. Arch Ophthalmol 1950;44:710–728.
- Ijaiya K, Grychtolik H: Horner-Syndrom bei euthyreoter Struma. Pädiatr Grenzgeb 1972;11:229–233.
- Billie JD, Wetzel WJ, Suen JY: Thyroid lymphoma with adjacent nerve paralysis. Arch Otolaryngol 1982;108:517–519.
- Levin R, Newman SA, Login IS: Bilateral Horner’s syndrome secondary to multinodular goiter. Ann Intern Med 1986;105:550–551.
Robinson D: Horner’s syndrome: A rare complication of multinodular goitre. NZ Med J 1987;100:392.
Lowry SR, Shinton RA, Jamieson G, Manche A: Benign multinodular goitre and reversible Horner’s syndrome. Br Med J 1988;296:529–530.
- Oravec D, Moravec R: Formen des Kompressionssyndroms bei Knoten- bzw. Retrosternalstruma im fortgeschrittenen Alter. Z Gesamte Inn Med 1988;43:425–427.
- Cengiz K, Aykin A, Demirci A, Diren B: Intrathoracic goiter with hyperthyroidism, tracheal compression, superior vena cava syndrome, and Horner’s syndrome. Chest 1990;97:1005–1006.
- Rabano A, La Sala M, Hernandez P, Barros JL: Thyroid carcinoma presenting as Pancoast’s syndrome. Thorax 1991;46:270–271.
- Kezachian B, Lebrun C, Thomas P, Santini J, Freychet P, Sadoul JL: Horner’s syndrome secondary to benign multimodular goitre with hyperthyroidism. Eur J Med 1993;2:440–441.
- Freeman JL, van den Brekel MW, Brown D: Carcinoma of the thyroid presenting as Horner’s syndrome. J Otolaryngol 1997;26:387–388.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.